51成人动漫

Oncology/Hematology

News, opinions and meeting coverage in oncology/hematology.

A computer rendering of a transparent head with brain metastases highlighted.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

Newest EGFR TKIs have changed the game for treating asymptomatic brain metastases

A photo of Randy Moss.

Randy Moss' Rare GI Cancer: Here's What to Know

Hall of Fame football player recently revealed his cholangiocarcinoma diagnosis

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

Study links strong relationships to better physical and emotional outcomes in myeloma care

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

Longer gaps between anti-BCMA agents associated with improved response rates, study finds

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

Experts talk about long-term data and the importance of infection prophylaxis

FDA APPROVED remestemcel-L (Ryoncil) over a photo of a bag of stem cells in a purple rubber-gloved hand.

FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids

Response rate of 70% at day 28 with remestemcel-L

FDA APPROVED ensartinib (Ensacove) over a computer rendering of lung cancer.

New First-Line Option for Advanced ALK-Positive Lung Cancer

In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor

A photo of a young man discussing his chemotherapy treatment with his male doctor.

What Comes After Cancer?

Alarming mental health challenges among young cancer survivors, especially males, demand action

SABCS over a photo of the Henry B. Gonzalez Convention Center in San Antonio, TX.

Skipping Chest-Wall Irradiation After Mastectomy in Intermediate-Risk Breast Cancer

No improvement in survival or impact on recurrence, but pending studies leave door ajar

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

Phase III trial sparks discussion on defining and managing high-risk smoldering myeloma

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

Randy Moss Has Cancer; Nancy Pelosi's Surgery; Possible Bird Flu Case Hospitalized

Health news and commentary gathered by 51成人动漫 staff

SABCS over a photo of the Henry B. Gonzalez Convention Center in San Antonio, TX.

A Setback for TNBC Monitoring With Circulating Tumor DNA in ZEST Trial

Study was stopped early due to enrollment issues, but lessons can still be learned

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Homing in on Anthracyclines' High-Risk Niche in Early Breast Cancer

Significant improvement in 5-year distant relapse-free interval with higher risk score

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Better Quality of Life With RT vs Endocrine Therapy in Older Breast Cancer Patients

Radiotherapy also resulted in fewer treatment-related adverse events

Onco Break over a computer rendering of a cancer cell.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

News, features, and commentary about cancer-related issues

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

No Apparent Harm From Omitting Lymph Node Dissection in Selected Breast Cancers

Nearly identical 5-year outcomes with no surgery, sentinel lymph node biopsy

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer

Study results are "historic," expert says

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Risk-Reducing Surgery May Benefit BRCA Carriers With Early-Onset Breast Cancer

Lower rates of mortality and cancer recurrence with mastectomy, salpingo-oophorectomy

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Skip Surgery for DCIS in Favor of Active Monitoring?

No invasive cancer increase at 2 years, but editorialists say data don't back active monitoring

A computer rendering of a heart and pulse.

Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk Patients

Signal largely driven by newly emerging arrhythmias

A photo of a male physician showing his male patient a tablet.

Industry Clinic 鈥� Ad Insights

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

ASH over a photo of San Diego Convention Center

Pulled Myeloma Drug Improves Survival in Trial

DREAMM-7 findings help pave the way for Blenrep's return

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Oral SERD Impresses in Advanced Breast Cancer With ESR1 Mutations

However, imlunestrant failed to improve PFS among entire trial population

ASH over a photo of San Diego Convention Center

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

Higher response rate, PFS, OS with cilta-cel, but ide-cel had lower rate of severe toxicity

ASHP over a photo of Ernest N. Morial Convention Center in New Orleans, LA.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

Study assessed pharmacist interventions for adverse events

ASH over a photo of San Diego Convention Center

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

But no overall survival benefit seen in confirmatory trial

ASH over a photo of San Diego Convention Center

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Benefit seen in all prespecified subgroups, including high-risk patients

A photo of a female gynecologist putting a cervical brush into a sample container with a female patient in the background.

USPSTF Plans Changes to Cervical Cancer Screening Recommendations

Self-collected HPV testing is a new addition

A photo of a nurse holding a bag of red blood cells.

Generous Blood Transfusions Not Beneficial for Some With Burst Brain Aneurysms

SAHARA rounds out this year's notable trials on blood transfusions in critically ill patients

ASH over a photo of San Diego Convention Center

Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later

Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds

ASH over a photo of San Diego Convention Center

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

New standard of care for patients in first remission?

ASH over a photo of San Diego Convention Center

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero

2024 YEAR IN REVIEW CLL over a computer rendering of CAR T cell therapy in chronic lymphocytic leukemia.

Year in Review: Chronic Lymphocytic Leukemia

Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more

A photo of a female physician at her desk talking to her male patient.

Industry Clinic 鈥� Ad Insights

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

ASH over a photo of San Diego Convention Center

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

Treatment tied to fewer vaso-occlusive pain events, hospitalizations versus placebo

ASH over a photo of San Diego Convention Center

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

AMPLIFY trial paves the way for FDA approval of acalabrutinib plus venetoclax

ASH over a photo of San Diego Convention Center

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive

ASH over a photo of San Diego Convention Center

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study

ASH over a photo of San Diego Convention Center

Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia

Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies

1

鈥�